Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Hershey stock jumps 8% after upbeat 2026 outlook, Q4 beat lifts HSY shares

Hershey stock jumps 8% after upbeat 2026 outlook, Q4 beat lifts HSY shares

Hershey shares surged about 8% to $222.61 Thursday after fourth-quarter earnings and a 2026 forecast beat estimates. Net sales rose 7% to $3.091 billion, with adjusted EPS at $1.71 per share. The company projects 2026 net sales growth of 4% to 5% and EPS between $8.20 and $8.52. Cocoa costs and falling volumes remain concerns for investors.
Bristol Myers Squibb stock rises on 2026 guidance as Eliquis price cut comes into view

Bristol Myers Squibb stock rises on 2026 guidance as Eliquis price cut comes into view

Bristol Myers Squibb shares rose 1.7% to $58.58 by midday Thursday, bucking a broader market decline, after the company issued a 2026 outlook projecting up to $47.5 billion in revenue. Quarterly revenue increased 1% to $12.5 billion, with growth portfolio sales up 16% and legacy drugs down 15%. The company expects Eliquis sales to rise despite U.S. price negotiations, but warned of a potential $2 billion drop in 2027 when European patents expire.
SoFi (SOFI) stock slides nearly 4% as JPMorgan stake filing lands — what traders watch next

SoFi (SOFI) stock slides nearly 4% as JPMorgan stake filing lands — what traders watch next

SoFi shares fell 3.7% to $19.98 Thursday after a JPMorgan filing showed its stake dropped below 5%, triggering less frequent disclosure requirements. The stock hit an intraday low of $19.20. JPMorgan analyst Reginald Smith upgraded SoFi to “Overweight” this week, maintaining a $31 price target. Broader fintech stocks and U.S. indexes also declined.
Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer stock price edges higher as Wall Street sizes up obesity-shot data and 2026 outlook

Pfizer shares rose 0.8% to $27.01 by early afternoon after the company reported up to 12.3% placebo-adjusted weight loss in a Phase 2b trial of its experimental obesity drug. Investors remain cautious amid concerns over patient dropout rates and side effects. Pfizer reaffirmed its 2026 forecast, projecting $59.5–$62.5 billion in revenue and $2.80–$3.00 adjusted earnings per share.
Visa stock rises against a falling market after $3 billion bond sale and “Visa & Main” launch

Visa stock rises against a falling market after $3 billion bond sale and “Visa & Main” launch

Visa shares rose 0.8% to $332.53 Thursday after the company launched its “Visa & Main” platform for small businesses and detailed a $3 billion multi-tranche bond sale. The new platform includes a $100 million working-capital facility with Lendistry. Visa outperformed a weaker U.S. market, with the S&P 500 ETF down 0.7%.
Uber stock rebounds nearly 4% as CFO switch and robotaxi push hit Wall Street

Uber stock rebounds nearly 4% as CFO switch and robotaxi push hit Wall Street

Uber shares rose 3.9% to $76.80 Thursday after a steep post-earnings drop, as the company named Balaji Krishnamurthy to replace CFO Prashanth Mahendra-Rajah, who will resign Feb. 16. Uber’s Q1 adjusted EPS forecast missed Wall Street estimates, while gross bookings guidance topped expectations. A UK tax law ruling will cut reported revenue margin by 3.5 points. Q4 trips and gross bookings each climbed 22% year-on-year.
Nebius stock drops again as AI jitters hit high-growth names ahead of Feb. 12 results

Nebius stock drops again as AI jitters hit high-growth names ahead of Feb. 12 results

Nebius Group N.V. shares fell 5.5% to $77.87 by midday Thursday amid a broader selloff in AI-related stocks. The Nasdaq hit a two-month low as investors reacted to Alphabet’s spending plans and Qualcomm’s outlook. Nebius will report fourth-quarter and full-year results on February 12. Freedom Capital set a $108 price target, citing the company’s GPU-as-a-service model.
JPMorgan stock drops nearly 3% as tech rout and softer jobs data rattle Wall Street

JPMorgan stock drops nearly 3% as tech rout and softer jobs data rattle Wall Street

JPMorgan Chase shares fell 2.9% to $308.13 by midday Thursday, outpacing declines at other major U.S. banks. The drop followed weaker labor data, a surge in layoff announcements, and a broader market selloff led by losses in Big Tech. Initial jobless claims rose to 231,000, while job openings hit their lowest since September 2020. Investors await the delayed U.S. payrolls report and inflation data next week.
Booking Holdings stock slips in midday trade as AI-fueled analyst calls collide on Wall Street

Booking Holdings stock slips in midday trade as AI-fueled analyst calls collide on Wall Street

Booking Holdings shares fell 1.6% to $4,534.04 Thursday as analysts clashed over whether AI poses a structural threat to online travel agencies. Citizens downgraded the stock, citing AI risks, while Mizuho upgraded it, calling the selloff overdone. Booking will report earnings on Feb. 18. Director Robert J. Mylod Jr. sold 40 shares last week at just over $5,000 each.
AST SpaceMobile (ASTS) stock sinks as AT&T taps Amazon Leo for satellite connectivity

AST SpaceMobile (ASTS) stock sinks as AT&T taps Amazon Leo for satellite connectivity

Shares of AST SpaceMobile dropped 7.8% to $95.45 by midday Thursday amid volatility in space-sector stocks. AT&T and Amazon Leo announced expanded collaboration on satellite and cloud services, drawing investor focus to U.S. telecom partnerships. Amazon Leo requested a 24-month FCC extension for its satellite network rollout. Pomerantz LLP is investigating claims for AST investors following a recent downgrade.
BNAI stock jumps as Brand Engagement Network scraps $50 million Yorkville equity line

BNAI stock jumps as Brand Engagement Network scraps $50 million Yorkville equity line

Brand Engagement Network shares rose 12.6% to $25.07 after the company canceled a $50 million standby equity purchase agreement with Yorkville Advisors, effective Feb. 4. The stock hit $30.70 earlier in the session. The firm reported 5.83 million shares outstanding and 3.38 million in public float. Closings for a $1.518 million private placement are set for Feb. 25 and March 25.
1 26 27 28 29 30 1,008

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop